OncoSec announces research collaboration with Roswell Park Comprehensive Cancer Center
OncoSec Medical announced a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate use of Roswell Park's intravital microscopy and OncoSec's proprietary plasmid, TAVOPLUS, in combination with the Company's recently announced APOLLO(TM) electroporation generator. June 17, 2019